Avalon Globocare Corp (NASDAQ:AVCO) Poised to Take Advantage of the Chinese Trade Deal
Avalon GloboCare Corp. (NASDAQ:AVCO), a leading global developer of cell-based technologies and therapeutics, is poised to take advantage of the Chinese trade deal optimism from last week. Avalon Globocare closed the week on Nov 7th just over even on the week however there was an increase in liquidity from the week before and 3/5 trading sessions closed a green signaling regimen investor optimism.
View full press release